- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
The Paroxetine 352 Bipolar Trial: A Study in Medical Ghostwriting
International Journal of Risk and Safety in Medicine 24 (4):221-231 (2012)
Abstract
The problem of ghostwriting in corporate-sponsored clinical trials is of concern to medicine, bioethics, and government agencies. We present a study of the ghostwritten archival report of an industry-sponsored trial comparing antidepressant treatments for bipolar depression: GlaxoSmithKline (GSK) paroxetine study 352.Author's Profile
My notes
Similar books and articles
Industry-Sponsored Ghostwriting in Clinical Trial Reporting: A Case Study.Leemon McHenry & Jon Jureidini - 2008 - Accountability in Research 15 (3):152-167.
Of Sophists and Spin-Doctors: Industry-Sponsored Ghostwriting and the Crisis of Academic Medicine.Leemon McHenry - 2010 - Mens Sana Monographs 8 (1):129.
Industry-Corrupted Psychiatric Trials.Leemon McHenry, Jon Jureidini & Jay Amsterdam - 2017 - Psychiatria Polska 51 (6):993-1008.
The Citalopram CIT-MD-18 Pediatric Depression Trial: A Deconstruction of Medical Ghostwriting, Data Manipulation and Academic Malfeasance.Leemon McHenry, Jon Jureidini & Jay Amsterdam - 2016 - International Journal of Risk and Safety in Medicine 28:33-43.
Profits and Plagiarism: The Case of Medical Ghostwriting.Tobenna D. Anekwe - 2010 - Bioethics 24 (6):267-272.
Crafting a public image: An empirical study of the ethics of ghostwriting. [REVIEW]Linda A. Riley & Stuart C. Brown - 1996 - Journal of Business Ethics 15 (7):711 - 720.
The Monsanto Papers: Poisoning the Scientific Well.Leemon McHenry - 2018 - International Journal of Risk and Safety in Medicine 29 (3):193-205.
Biomedical Research and Corporate Interests: A Question of Academic Freedom.L. McHenry - 2008 - Mens Sana Monographs 6 (1):146.
On the Proposed Changes to the Credibility Gap in Industry-Supported Biomedical Research: A Critical Evaluation.Leemon McHenry & Jon Jureidini - 2012 - Ethical Human Psychology and Psychiatry 14 (3):156-161.
Whatever Happened to Human Experimentation?Carl Elliott - 2015 - Hastings Center Report 46 (1):8-11.
Post-trial period surveillance for randomised controlled cardiovascular studies: submitted protocols, consent forms and the role of the ethics board.M. I. Zia, R. Heslegrave & G. E. Newton - 2011 - Journal of Medical Ethics 37 (12):762-765.
Did we describe what you meant? Findings and methodological discussion of an empirical validation study for a systematic review of reasons.Marcel Mertz, Neema Sofaer & Daniel Strech - 2014 - BMC Medical Ethics 15 (1):69.
Analytics
Added to PP
2018-07-19
Downloads
0
6 months
0
2018-07-19
Downloads
0
6 months
0
Historical graph of downloads
Sorry, there are not enough data points to plot this chart.
Author's Profile
Citations of this work
The ICMJE Recommendations and pharmaceutical marketing – strengths, weaknesses and the unsolved problem of attribution in publication ethics.Alastair Matheson - 2016 - BMC Medical Ethics 17 (1):1-10.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-4c2ch uwo